| 영문 | cardiovascular system | 한글 | 심장혈관계 |
|---|---|---|---|
| 설명 | 신체의 혈액순환을 담당하는 기관. 즉 심장과 혈관을 통칭해서 이르는 말이다. |
||
| 영문 | sports medicine | 한글 | 스포츠의학 |
|---|---|---|---|
| 설명 | 스포츠가 사람의 몸에 미치는 생리적 영향과 건강 관리, 신체발달, 경기 능력 향상에 관하여 연구하는 학문. 의학의 한 분야이다. 해부학-생리학-생화학 등의 기초 분야와 임상 분야를 망라한 의학적 지식을 바탕으로 하여 스포츠와 인체의 관계를 연구하고 반영시킨다. 스포츠의학은 생리학적-해부학적-정신과학적-생화학적인 운동의 효과를 평가 분석하여 이를 토대로 훈련방법의 개선점을 추구하고 스포츠 외상의 예방과 치료지침을 마련하여 선수들의 영양관리는 물론 환경변화에 대처하는 방안을 마련하는 인체와 스포츠 전반에 관한 폭 넓은 학문이다. |
||
| 영문 | preventive medicine | 한글 | 예방의학 |
|---|---|---|---|
| 설명 | 병의 예방에 중점을 둔 위생학의 한 분야. 보통 치료의학의 대응어로 쓰인다. 의학은 건강을 유지-증진하고 질병을 예방하는 것이며, 병이 났을 때는 건강을 회복시키고 재활시켜서 사회에 적응할 수 있도록 하는 것이다. 일반적으로 의학을 기초의학-임상의학-예방의학으로 크게 나누는 입장도 있다. 질병이 발생하는 데에는 세가지 요인이 있다. 첫째는 물리적-생물학적-사회적 -문화적-경제적 환경이다. 둘째는 숙주(인간)이며, 여기에는 연령-성-영양-생활습관-의료형태 등이 관련된다. 셋째는 병원체로서 세균-물리적 요인 및 화학물질 등을 들수 있다. 인간과 병원체는 환경을 지렛대로 하는 관계를 가진다. |
||
| 영문 | medicine | 한글 | 의학 |
|---|---|---|---|
| 설명 | 인간을 질병으로부터 구하고 건강법을 모색하는 학문. 의학은 인류의 역사와 더불어 경험의료로서 존재해 왔으며, 일반과학이 진보함에 따라서 독자성을 지닌 과학으로 발전하여 인체에 관한 연구와 질병의 예방 및 치료를 연구하는 학문이라고 정의된다. 의학은 질병에 관해서 연구하고, 그 예방이나 진단-치료 및 건강의 유지와 증진을 목적으로 하는 학문이다. 역사적으로 병을 고치는 것, 즉 기술적 또는 응용적 측면이라고 할 수 있는 의료가 먼저 발달하고 중요시되어 왔으며, 그런 점에서 임상의학이 먼저 발달하였고, 기초의학과 예방의학이 발전하게 되었다. 의학은 단순히 응용적 과학이 아니고, 가장 고등한 생물로서의 인간을 대상으로 한 생물과학이며 생명과학의 발전에 크게 기여하였고, 또 하고 있다. |
||
| 영문 | rehabilitation medicine | 한글 | 재활의학 |
|---|---|---|---|
| 설명 | 장애자를 신체적-정신적으로 가능한 최대한도까지 정상적으로 회복시키기 위한 학문. 의학의 한 분야이다. |
||
| CC | calcaneal-cuboid; calcium cyclamate; cardiac catheterization; cardiac contusion; cardiac cycle; card... |
|---|---|
| CVS | cardiovascular surgery; cardiovascular system; challenge virus strain; chorionic villi sampling; cle... |
| DPM | Diploma in Psychological Medicine; discontinue previous medication; Doctor of Physical Medicine; Doc... |
| APM | Academy of Parapsychology and Medicine; Academy of Physical Medicine; Academy of Psychosomatic Medic... |
| CR | calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio... |
| CCTs | Controlled clinical trials |
|---|---|
| RCT | Randomized controlled clinical trials |
| ACTG | AIDS Clinical Trials Group |
| PACTG | Paediatric AIDS Clinical Trials Group |
| ASCVD | Atherosclerotic cardiovascular disease |
| randomised controlled trials | Clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table. Treatment allocations using coin flips, odd-even numbers, patient social security numbers, days of the week, medical record numbers, or other such pseudo- or quasi-random processes, are not truly randomised and trials employing any of these techniques for patient assignment are designated simply controlled clinical trials. (12 Dec 1998) |
|---|---|
| controlled clinical trials | Clinical trials involving one or more test treatments, at least one control treatment, specified outcome measures for evaluating the studied intervention, and a bias-free method for assigning patients to the test treatment. The treatment may be drugs, devices, or procedures studied for diagnostic, therapeutic, or prophylactic effectiveness. Control measures include placebos, active medicines, no-treatment, dosage forms and regimens, historical comparisons, etc. When randomization using mathematical techniques, such as the use of a random numbers table, is employed to assign patients to test or control treatments, the trials are characterised as randomised controlled trials. However, trials employing treatment allocation methods such as coin flips, odd-even numbers, patient social security numbers, days of the week, medical record numbers, or other such pseudo- or quasi-random processes, are simply designated as controlled clinical trials. (12 Dec 1998) |
| clinical research trials | Evaluating the safety and effectiveness of medications or medical devices by monitoring their effects on large groups of people. Clinical medical trials sponsored by the U. S. Government are listed on a web site of the National Institutes of Health (NIH). The NIH Clinical Centre intends to make details of current clinical research studies for various diseases available over the Internet to increase opportunities for patients and physicians to participate in clinical investigations. (12 Dec 1998) |
| clinical trials | Medical research studies conducted with volunteers. Each study is designed to answer scientific questions and to find better ways to prevent, detect, or treat cancer. (12 Dec 1998) |
| clinical trials, phase I | Studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the u.s. And in other countries. (12 Dec 1998) |
| clinical trials, phase II | Studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the u.s. And in other countries. (12 Dec 1998) |
| clinical trials, phase III | Comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the u.s. And in other countries. (12 Dec 1998) |
| clinical trials, phase IV | Planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the u.s. And in other countries. (12 Dec 1998) |
| cardiovascular | <cardiology, physiology> Pertaining to the heart and blood vessels. (18 Nov 1997) |
| cardiovascular abnormalities | Congenital structural abnormalities of the cardiovascular system. (12 Dec 1998) |
| cardiovascular agents | Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. (12 Dec 1998) |
| cardiovascular deconditioning | A change in cardiovascular function, especially after periods of actual or simulated weightlessness or diminished power or strength, probably related to the shift of a quantity of blood from the lower limbs to the thorax, resulting in reflex diuresis and a reduction of blood volume. (12 Dec 1998) |
| cardiovascular physiology | Functions and activities of the cardiovascular system as a whole or of any of its parts. (12 Dec 1998) |
| cardiovascular radiology | The clinical subspecialty of radiology concerned with diagnosis and treatment of diseases of the vascular system. (05 Mar 2000) |
| cardiovascular surgery | The use of surgery to fix disorders of the heartand/or blood vessels. (09 Oct 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|